Effects of dopamine antagonists in a two-way active avoidance procedure in rats: interactions with 8-OH-DPAT, ritanserin, and prazosin
暂无分享,去创建一个
[1] C J Niemegeers,et al. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? , 1966, Arzneimittel-Forschung.
[2] S. Gershon,et al. MJ 9022: correlation between neuroleptic potential and stereotypy. , 1975, Current therapeutic research, clinical and experimental.
[3] S. Matthysse. DOPAMINE AND THE PHARMACOLOGY OF SCHIZOPHRENIA: THE STATE OF THE EVIDENCE* , 1975 .
[4] S. Snyder,et al. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. , 1976, Science.
[5] P. Seeman,et al. Antipsychotic drug doses and neuroleptic/dopamine receptors , 1976, Nature.
[6] A. Uzan,et al. Differential effects of typical and atypical neuroleptics on alpha-noradrenergic and dopaminergic postsynaptic receptors , 1979, Neuropharmacology.
[7] R. Baldessarini,et al. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. , 1980, Annual review of neuroscience.
[8] C. Marsden,et al. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs , 1980, Psychological Medicine.
[9] Sakutaro Tadokoro,et al. Correlation between antiavoidance activities of antipsychotic drugs in rats and daily clinical doses , 1981, Pharmacology Biochemistry and Behavior.
[10] J. Arnt,et al. Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade. , 2009, Acta pharmacologica et toxicologica.
[11] M. Sanghera,et al. Dopamine receptor antagonism by the novel antianxiety drug, buspirone , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[12] B. Bunney,et al. Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[13] S O Ogren,et al. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. , 1985, Biochemical pharmacology.
[14] J. Hyttel,et al. Further studies of the mechanism behind scopolamine-induced reversal of antistereotypic and cataleptogenic effects of neuroleptics in rats. , 2009, Acta pharmacologica et toxicologica.
[15] C. Braestrup,et al. Some atypical neuroleptics inhibit [3H]SCH 23390 binding in vivo. , 1986, European journal of pharmacology.
[16] M. Latranyi,et al. Similarity of clozapine and SCH 23390 in reserpinized rats suggests a common mechanism of action. , 1987, European journal of pharmacology.
[17] L. Cervo,et al. 8-hydroxy-2-(di-N-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis , 1988, Neuropharmacology.
[18] B. McMillen,et al. Reversal of neuroleptic‐induced catalepsy by novel aryl‐piperazine anxiolytic drugs , 1988, The Journal of pharmacy and pharmacology.
[19] H. Meltzer,et al. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. , 1989, The Journal of pharmacology and experimental therapeutics.
[20] S. Ahlénius. Antipsychotic-like properties of the 5-HT1A agonist 8-OH-DPAT in the rat. , 1989, Pharmacology & toxicology.
[21] J. Leysen,et al. Receptor occupancy by ritanserin and risperidone measured using ex vivo autaradiography , 1989, Brain Research.
[22] L. Adler,et al. Effects of buspirone in seven schizophrenic subjects. , 1990, Journal of clinical psychopharmacology.
[23] J. Lieberman,et al. Update on the clinical efficacy and side effects of clozapine. , 1991, Schizophrenia bulletin.
[24] Neuroleptic drugs and dopamine receptors. , 1991 .
[25] D. Goff,et al. An open trial of buspirone added to neuroleptics in schizophrenic patients. , 1991, Journal of clinical psychopharmacology.
[26] A. Cools,et al. The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine. , 1991, European journal of pharmacology.
[27] Eric R. Marsh,et al. Do Central Antiadrenergic Actions Contribute to the Atypical Properties of Clozapine? , 1992, British Journal of Psychiatry.
[28] F. Colpaert,et al. Behavioral pharmacology of antagonists at 5-HT2/5-HT1C receptors , 1992, Neuroscience & Biobehavioral Reviews.
[29] B. Ellenbroek,et al. Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs. , 1993, Pharmacology & therapeutics.
[30] W. Koek,et al. Binding of antipsychotic drugs at α1A- and α1B-adrenoceptors: risperidone is selective for the α1B-adrenoceptors , 1993 .
[31] W. Koek,et al. Binding of antipsychotic drugs at alpha 1A- and alpha 1B-adrenoceptors: risperidone is selective for the alpha 1B-adrenoceptors. , 1993, European journal of pharmacology.
[32] T. Barnes,et al. Acute exacerbation of psychosis with buspirone? , 1993, Journal of psychopharmacology.
[33] P. Botter,et al. Ritanserin, a Selective 5-HT2/1C Antagonist, and Negative Symptoms in Schizophrenia , 1993, British Journal of Psychiatry.
[34] A Labelle,et al. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. , 1993, Journal of clinical psychopharmacology.
[35] I. Lucki,et al. Serotonergic involvement in haloperidol-induced catalepsy. , 1993, The Journal of pharmacology and experimental therapeutics.
[36] A. Cools,et al. Peripheral and central adrenoceptor modulation of the behavioural effects of clozapine in the paw test , 1994, British journal of pharmacology.
[37] C. Czudek,et al. Common profile of D1 receptor antagonists and atypical antipstchotic drugs revealed by analysis of dopamine turnover , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[38] A. Cools,et al. Combined antagonism of adrenoceptors and dopamine and 5-HT receptors underlies the atypical profile of clozapine. , 1994, European journal of pharmacology.
[39] A. Cools,et al. The Role of Serotonin Receptor Subtypes in the Behavioural Effects of Neuroleptic Drugs. A Paw Test Study in Rats , 1994, The European journal of neuroscience.
[40] P. Bonaventure,et al. In vitro receptor binding and in vivo receptor occupancy in rat and guinea pig brain: risperidone compared with antipsychotics hitherto used. , 1995, Japanese journal of pharmacology.
[41] J. Peuskens. Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus Haloperidol , 1995, British Journal of Psychiatry.